FindTrial
Sign In

N-Acetytilcysteine Versus placebo for the prevention of Acute Reduction in Renal function after primary Angioplasty (NoVARA) - NoVARA

N-Acetytilcysteine Versus placebo for the prevention of Acute Reduction in Renal function after primary Angioplasty (NoVARA) - NoVARA

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2010-022952-22-IT
Enrollment
Unknown
Registered
2010-12-17
Start date
2010-10-22
Completion date
Unknown
Last updated
2014-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patient with ST elevation myocardial acute infarction MedDRA version: 9.1 Level: SOC Classification code 10007541

Interventions

Trade Name: FLUIMUCIL UROL. Pharmaceutical Form: Solution for injection INN or Proposed INN: Acetylcysteine Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 300- Pha

Sponsors

AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with aged 18 years and 90 yearsa dmitted in hospital for acute coronary syndrome with persistente ST elevation and chest pain less than 12 hours Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: shock cardiogenic, chronic dialisis, pregnancy, allergy to N-acetylcysteine, inability to obtain informed consent

Design outcomes

Primary

MeasureTime frame
Main Objective: determinate the effects of N-Acetytilcysteine versus placebo to prevent acute reduction in renal function after primary angioplasty;Secondary Objective: not avalable;Primary end point(s): assess the development of contrast induced acute renal failure—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026